Pneumoconiosis surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(6 intermediate revisions by the same user not shown)
Line 4: Line 4:


==Overview==
==Overview==
Surgical intervention is not recommended for the management of [disease name].
Surgical intervention is not recommended for the management of [[pneumoconiosis]]. Severe cases of the condition can be treated with a lung [[Organ transplant|transplant]]. <ref name="pmid23708110">{{cite journal| author=Cullinan P, Reid P| title=Pneumoconiosis. | journal=Prim Care Respir J | year= 2013 | volume= 22 | issue= 2 | pages= 249-52 | pmid=23708110 | doi=10.4104/pcrj.2013.00055 | pmc=6442808 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23708110  }} </ref>
 
OR
 
Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]
 
OR
 
The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
 
OR
 
The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
 
OR
 
Surgery is the mainstay of treatment for [disease or malignancy].


==Indications==
==Indications==


*Surgical intervention is not recommended for the management of [disease name].
*[[Surgery]] is not the [[first-line treatment]] option for patients with [[pneumoconiosis]]. [[Surgery]] is usually reserved for patients with either: <ref name="pmid32310362">{{cite journal| author=| title=StatPearls | journal= | year= 2021 | volume=  | issue=  | pages=  | pmid=32310362 | doi= | pmc= | url= }} </ref> <ref name="pmid29773095">{{cite journal| author=Li J, Yao W, Hou JY, Zhang L, Bao L, Chen HT | display-authors=etal| title=The Role of Fibrocyte in the Pathogenesis of Silicosis. | journal=Biomed Environ Sci | year= 2018 | volume= 31 | issue= 4 | pages= 311-316 | pmid=29773095 | doi=10.3967/bes2018.040 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29773095  }} </ref> <ref name="pmid22071439">{{cite journal| author=Singer JP, Chen H, Phelan T, Kukreja J, Golden JA, Blanc PD| title=Survival following lung transplantation for silicosis and other occupational lung diseases. | journal=Occup Med (Lond) | year= 2012 | volume= 62 | issue= 2 | pages= 134-7 | pmid=22071439 | doi=10.1093/occmed/kqr171 | pmc=3283165 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22071439  }} </ref> <ref name="pmid25398119">{{cite journal| author=Balmes JR, Abraham JL, Dweik RA, Fireman E, Fontenot AP, Maier LA | display-authors=etal| title=An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease. | journal=Am J Respir Crit Care Med | year= 2014 | volume= 190 | issue= 10 | pages= e34-59 | pmid=25398119 | doi=10.1164/rccm.201409-1722ST | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25398119  }} </ref>
OR
**Advanced disease
*Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either:
**[[Pulmonary hypertension]]
**[Indication 1]
**[[Respiratory failure]]
**[Indication 2]
**[[Cor pulmonale]]
**[Indication 3]
*The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either:
**[Indication 1]
**[Indication 2]  
**[Indication 3]
 
==Surgery==
 
*The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
OR
*Surgery is the mainstay of treatment for [disease or malignancy].
 
==Contraindications==
 


==References==
==References==

Latest revision as of 20:06, 28 April 2021

Pneumoconiosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pneumoconiosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pneumoconiosis surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pneumoconiosis surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pneumoconiosis surgery

CDC on Pneumoconiosis surgery

Pneumoconiosis surgery in the news

Blogs on Pneumoconiosis surgery

Directions to Hospitals Treating Pneumoconiosis

Risk calculators and risk factors for Pneumoconiosis surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dushka Riaz, MD

Overview

Surgical intervention is not recommended for the management of pneumoconiosis. Severe cases of the condition can be treated with a lung transplant. [1]

Indications

References

  1. Cullinan P, Reid P (2013). "Pneumoconiosis". Prim Care Respir J. 22 (2): 249–52. doi:10.4104/pcrj.2013.00055. PMC 6442808. PMID 23708110.
  2. "StatPearls". 2021. PMID 32310362 Check |pmid= value (help).
  3. Li J, Yao W, Hou JY, Zhang L, Bao L, Chen HT; et al. (2018). "The Role of Fibrocyte in the Pathogenesis of Silicosis". Biomed Environ Sci. 31 (4): 311–316. doi:10.3967/bes2018.040. PMID 29773095.
  4. Singer JP, Chen H, Phelan T, Kukreja J, Golden JA, Blanc PD (2012). "Survival following lung transplantation for silicosis and other occupational lung diseases". Occup Med (Lond). 62 (2): 134–7. doi:10.1093/occmed/kqr171. PMC 3283165. PMID 22071439.
  5. Balmes JR, Abraham JL, Dweik RA, Fireman E, Fontenot AP, Maier LA; et al. (2014). "An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease". Am J Respir Crit Care Med. 190 (10): e34–59. doi:10.1164/rccm.201409-1722ST. PMID 25398119.

Template:WH Template:WS